Lifestyles and oxidative stress in type 2 diabetic patients

Author： Kotani Kazuhiko Sakane Naoki Tsuzaki Kokoro Matsuoka Yukiyo Sano Yoshiko Hamada Taku Yamada Kazunori

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.68, Iss.7, 2008-01, pp. : 516-518

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti‐oxidative effect of the β‐blocker carvedilol on diabetic nephropathy in non‐obese type 2 diabetic rats

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 9, 2015-09 ,pp. : 972-978

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors affecting the efficacy of starting insulin treatment in Type 2 diabetic patients

By Vähätalo Markku Rönnemaa Tapani Viikari Jorma

Scandinavian Journal of Primary Health Care, Vol. 21, Iss. 4, 2003-12 ,pp. : 230-236

Informa Healthcare

Access to resources Recommend Favorite

Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients

By Derosa Giuseppe Maffioli Pamela Salvadeo Sibilla A. T. Ferrari Ilaria Gravina Alessia Mereu Roberto Palumbo Ilaria D'angelo Angela Cicero Arrigo F. G.

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1973-1983

Informa Healthcare

Access to resources Recommend Favorite

Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications

By Čolak Emina Majkić Nada Stanković Sanja Srecković Vesna Djordjević Predrag Lalić Katarina Lalić NebojšA

Annals of Medicine, Vol. 37, Iss. 8, 2005-12 ,pp. : 613-620

Informa Healthcare

Access to resources Recommend Favorite

Association of Metabolic Syndrome with Microalbuminuria in Non-Hypertensive Type 2 Diabetic Patients

Nephron Clin Pract, Vol. 106, Iss. 3, 2007-05 ,pp. : c98-c103

Karger

Access to resources Recommend Favorite